Crossmark

Optimal sequencing of chemotherapy with chemoradiotherapy based on TNM stage classification and EBV DNA in locoregionally advanced nasopharyngeal carcinoma

Crossref DOI link: https://doi.org/10.1186/s40880-019-0398-0

Published Online: 2019-10-25

Published Print: 2019-12

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Liu, Li‐Ting

Chua, Melvin L. K.

Tao, Yungan

Tang, Lin‐Quan

Mai, Hai‐Qiang
Funding

Funding for this research was provided by:

National Basic Research Program of China (2017YFC0908500)

National Basic Research Program of China (2017YFC1309003)

National Natural Science Foundation of China (81425018)

National Natural Science Foundation of China (81672868)

National Natural Science Foundation of China (81602371)

AstraZeneca

Varian Medical Systems

Sanofi
License Information

Version of Record valid from 2019-10-25
More Information

Publication History

Received: 2019-09-20

Accepted: 2019-09-23

Published: 2019-10-25

Document is current

Any future updates will be listed below